Literature DB >> 12357453

Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort.

Robert F Ritchie1, Glenn E Palomaki, Louis M Neveux, Olga Navolotskaia, Thomas B Ledue, Wendy Y Craig.   

Abstract

The principal considerations driving iron status evaluation are clinical concern for anemia and the possibility of iron-storage disease. Most often, the circulating levels of transferrin (or total iron binding capacity) and serum iron are measured and the percentage of transferrin saturation (TSAT) is then computed. Optimally, reference ranges for these analytes should exclude the effects of the acute phase response, nutritional status, estrogen effect, specific genetic disorders, liver disease, and blood transfusion. The current study reports reference ranges for serum iron and TSAT within a cohort of over 55,000 Caucasians from northern New England, tested in our laboratory between 1994 and 1999. Measurements were standardized against serum reference material (SRM) 937 (for iron) and certified reference material (CRM) 470 (also called reference preparation for proteins in human serum (RPPHS)) (for transferrin), and analyzed using a previously published approach. Individual cases with evidence of inflammation (C-reactive protein > or =10 mg/L), or iron overload (TSAT >80% for males and >70% for females) or serum iron values <5 micro mol/L, were removed. Among the referent individuals, iron and TSAT levels rose slightly until the teen years, at which time levels in males increased while those in females remained essentially constant. Between 20 and 70 years of age, males had 10-15% higher iron levels and 15-20% higher TSAT levels than females. When values were expressed as multiples of the age- and gender-specific median levels, the serum iron and TSAT observations fit log-Gaussian distributions reasonably well from the 20th to 99th centile, and the 10th to the 99th centile, respectively. After normalization, the Gaussian parameters can be used to assign a corresponding centile to an individual's measurement, simplifying interpretation. These data provide new and more detailed reference ranges for serum iron and TSAT. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12357453      PMCID: PMC6807751          DOI: 10.1002/jcla.10048

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  30 in total

1.  [Sex-specific differences of serum proteins in adults and influence of oral hormonal contraceptives on serum protein composition].

Authors:  D Dotchev; N Liappis; H Hungerland
Journal:  Clin Chim Acta       Date:  1973-03-30       Impact factor: 3.786

2.  Relationship of day-to-day variation of serum iron concentrations to iron-binding capacity in healthy young women.

Authors:  B E Statland; P Winkel
Journal:  Am J Clin Pathol       Date:  1977-01       Impact factor: 2.493

3.  Variations in iron-status measures during the menstrual cycle.

Authors:  I Kim; E A Yetley; M S Calvo
Journal:  Am J Clin Nutr       Date:  1993-11       Impact factor: 7.045

4.  Influence of blood donation and iron supplementation on indicators of iron status.

Authors:  T B Ledue; W J Craig; R F Ritchie; J E Haddow
Journal:  Clin Chem       Date:  1994-07       Impact factor: 8.327

5.  Concentration of serum prealbumin and retinol-binding proteins during pregnancy.

Authors:  G P Giacoia
Journal:  South Med J       Date:  1984-10       Impact factor: 0.954

6.  Serum protein pattern in normal pregnancy with special reference to acute-phase reactants.

Authors:  K Haram; K Augensen; S Elsayed
Journal:  Br J Obstet Gynaecol       Date:  1983-02

7.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

8.  Total serum protein and serum protein fractions in depression: relationships to depressive symptoms and glucocorticoid activity.

Authors:  M Maes; A Wauters; H Neels; S Scharpé; A Van Gastel; P D'Hondt; D Peeters; P Cosyns; R Desnyder
Journal:  J Affect Disord       Date:  1995-04-16       Impact factor: 4.839

9.  Salicylate-induced increases in free triiodothyronine in human serum. Evidence of inhibition of triiodothyronine binding to thyroxine-binding globulin and thyroxine-binding prealbumin.

Authors:  P R Larsen
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

Review 10.  Transthyretin (prealbumin) in health and disease: nutritional implications.

Authors:  Y Ingenbleek; V Young
Journal:  Annu Rev Nutr       Date:  1994       Impact factor: 11.848

View more
  13 in total

1.  Reference distributions for complement proteins C3 and C4: a comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  Reference distributions for serum iron and transferrin saturation: a comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

3.  Reference distributions for apolipoproteins AI and B and the apolipoprotein B/AI ratios: a practical and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Thomas B Ledue; Wendy Y Craig; Santica Marcovina; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

4.  Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

5.  Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

Review 6.  The neglected significance of "antioxidative stress".

Authors:  B Poljsak; I Milisav
Journal:  Oxid Med Cell Longev       Date:  2012-05-08       Impact factor: 6.543

7.  Sex- and age-dependent association of SLC11A1 polymorphisms with tuberculosis in Chinese: a case control study.

Authors:  Kim Hung Leung; Shea Ping Yip; Wa Sang Wong; Lap San Yiu; Kam Keung Chan; Wai Man Lai; Eudora Y D Chow; Che Kit Lin; Wing Cheong Yam; Kin Sang Chan
Journal:  BMC Infect Dis       Date:  2007-03-19       Impact factor: 3.090

8.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

9.  A New Transferrin Receptor Aptamer Inhibits New World Hemorrhagic Fever Mammarenavirus Entry.

Authors:  Keith E Maier; Rohit K Jangra; Kevin R Shieh; David K Cureton; Hui Xiao; Erik L Snapp; Sean P Whelan; Kartik Chandran; Matthew Levy
Journal:  Mol Ther Nucleic Acids       Date:  2016-05-24       Impact factor: 10.183

10.  An RNA alternative to human transferrin: a new tool for targeting human cells.

Authors:  Samantha E Wilner; Brian Wengerter; Keith Maier; Maria de Lourdes Borba Magalhães; David Soriano Del Amo; Supriya Pai; Felipe Opazo; Silvio O Rizzoli; Amy Yan; Matthew Levy
Journal:  Mol Ther Nucleic Acids       Date:  2012-05-15       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.